DK1996160T3 - Bioresorberbar sammensætning med kontrolleret frigivelse - Google Patents

Bioresorberbar sammensætning med kontrolleret frigivelse

Info

Publication number
DK1996160T3
DK1996160T3 DK07711943.6T DK07711943T DK1996160T3 DK 1996160 T3 DK1996160 T3 DK 1996160T3 DK 07711943 T DK07711943 T DK 07711943T DK 1996160 T3 DK1996160 T3 DK 1996160T3
Authority
DK
Denmark
Prior art keywords
ceramic
pharmaceutical composition
preparation
controlled
controlled release
Prior art date
Application number
DK07711943.6T
Other languages
English (en)
Inventor
Hans Lennernaes
Niklas Axen
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidds Ab filed Critical Lidds Ab
Application granted granted Critical
Publication of DK1996160T3 publication Critical patent/DK1996160T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07711943.6T 2006-03-14 2007-03-14 Bioresorberbar sammensætning med kontrolleret frigivelse DK1996160T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200600361 2006-03-14
PCT/EP2007/002250 WO2007104549A2 (en) 2006-03-14 2007-03-14 Bioresorbable controlled-release composition

Publications (1)

Publication Number Publication Date
DK1996160T3 true DK1996160T3 (da) 2010-07-05

Family

ID=36602790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07711943.6T DK1996160T3 (da) 2006-03-14 2007-03-14 Bioresorberbar sammensætning med kontrolleret frigivelse

Country Status (18)

Country Link
US (1) US8999389B2 (da)
EP (1) EP1996160B8 (da)
JP (1) JP5216601B2 (da)
KR (1) KR101378174B1 (da)
CN (1) CN101431984B (da)
AT (1) ATE460154T1 (da)
AU (1) AU2007224651B8 (da)
CA (1) CA2644429C (da)
DE (1) DE602007005231D1 (da)
DK (1) DK1996160T3 (da)
ES (1) ES2342123T3 (da)
HK (1) HK1129061A1 (da)
IL (1) IL193973A (da)
MX (1) MX2008011606A (da)
PL (1) PL1996160T3 (da)
RU (1) RU2405537C2 (da)
WO (1) WO2007104549A2 (da)
ZA (1) ZA200807881B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL181834A (en) 2006-04-02 2011-04-28 Iscar Ltd Cutting head and adaptor
DK2376135T3 (da) * 2008-11-27 2015-08-31 Lidds Ab Anvendelse af carboxymethylcellulose til kontrol med udsprøjtelighed og størkningstid for sammensætninger indeholdende ét eller flere bioresorberbare keramiske materialer
EP2396037A4 (en) * 2009-02-12 2012-12-19 Aduro Material Ab COMPOSITION WITH A BIODEGRADABLE CARRIER FOR THE CONTROLLED DISPOSAL OF MEDICAMENTS
MX2016008283A (es) * 2013-12-23 2016-09-08 Bcn Peptides Sa Analogos de bicalutamida o (s)-bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acumulo lisosomal o glucogenosis.
KR102551708B1 (ko) 2015-06-04 2023-07-06 크리티테크, 인크. 수집 장치 및 사용 방법
EP3439635B1 (en) 2016-04-04 2020-12-09 Crititech, Inc. Formulations for solid tumor treatment
MX2019004414A (es) 2016-10-17 2019-09-02 Lidds Ab Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas.
CA3063420A1 (en) 2017-06-09 2018-12-13 Crititech, Inc. Treatment of epithelial cysts by intracystic injection of antineoplastic particles
JP6840869B2 (ja) 2017-06-14 2021-03-10 クリチテック，インコーポレイテッド 肺障害の治療方法
KR20200064112A (ko) 2017-10-03 2020-06-05 크리티테크, 인크. 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
RU2683255C1 (ru) * 2018-03-06 2019-03-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биоактивный композиционный материал для замещения костных дефектов и способ его получения
WO2019170912A1 (en) 2018-03-09 2019-09-12 Lidds Ab Bioresorbable controlled-release compositions with sting modulating molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797758A (en) * 1972-06-16 1974-03-19 Giulini Gmbh Geb Method of producing finely dispersed alpha calcium sulfate hemihydrate
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
US5055307A (en) 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
EP0941079B1 (en) * 1996-10-16 2007-12-19 Etex Corporation Bioceramic compositions
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6030635A (en) * 1998-02-27 2000-02-29 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
GB0020610D0 (en) 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
US6730324B2 (en) * 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
SE522749C2 (sv) * 2002-03-04 2004-03-02 Cerbio Tech Ab Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning
EP1680089B1 (en) 2003-10-22 2013-09-11 Lidds AB Composition comprising biodegradable hydrating ceramics for controlled drug delivery

Also Published As

Publication number Publication date
AU2007224651B8 (en) 2011-10-27
EP1996160B8 (en) 2010-05-12
RU2008140519A (ru) 2010-04-20
PL1996160T3 (pl) 2010-09-30
JP5216601B2 (ja) 2013-06-19
DE602007005231D1 (de) 2010-04-22
AU2007224651A1 (en) 2007-09-20
CN101431984A (zh) 2009-05-13
IL193973A (en) 2012-07-31
MX2008011606A (es) 2008-09-22
AU2007224651A8 (en) 2011-10-27
HK1129061A1 (en) 2009-11-20
AU2007224651B2 (en) 2011-10-13
IL193973A0 (en) 2009-09-22
ZA200807881B (en) 2009-10-28
JP2009529554A (ja) 2009-08-20
WO2007104549A2 (en) 2007-09-20
US8999389B2 (en) 2015-04-07
CA2644429C (en) 2014-07-29
KR101378174B1 (ko) 2014-03-27
RU2405537C2 (ru) 2010-12-10
WO2007104549A8 (en) 2007-12-13
WO2007104549A3 (en) 2007-11-08
ATE460154T1 (de) 2010-03-15
ES2342123T3 (es) 2010-07-01
US20090118215A1 (en) 2009-05-07
EP1996160A2 (en) 2008-12-03
CA2644429A1 (en) 2007-09-20
CN101431984B (zh) 2013-07-10
EP1996160B1 (en) 2010-03-10
KR20080108128A (ko) 2008-12-11

Similar Documents

Publication Publication Date Title
DK1996160T3 (da) Bioresorberbar sammensætning med kontrolleret frigivelse
WO2006044504A8 (en) Cgrp receptor antagonists
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
WO2006099268A3 (en) Cgrp receptor antagonists
BRPI0715893A2 (pt) composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
WO2003028641A3 (en) Mch receptor antagonists
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
WO2006047196A3 (en) Cgrp receptor antagonists
MY156822A (en) Indole derivatives as s1p1 receptor agonists
WO2006031491A3 (en) Tricyclic anilide spirolactam cgrp receptor antagonists
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
ATE553105T1 (de) Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer
WO2006031610A3 (en) Bicyclic anilide spirolactam cgrp receptor antagonists
CU23615B7 (es) Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2005115392A8 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
WO2006041830A3 (en) Cgrp receptor antagonists
CL2008003067A1 (es) Compuesto 2-[3-(2,2-difluoro-benzo[1,3]dioxol-5-ilamino)-5-(2,6-dimetil-piridin-4-il)-[1,2,4]triazol-1-il]-n-etil-acetamida, modulador de receptores nicotinicos alfa-7; proceso de preparacion; composicion farmaceutica y su proceso de preparacion; y su uso en el tratamiento de trastornos psicoticos, intelectuales, inflamatorios.
WO2008048801A3 (en) Phenylalkylamino carbamate compositions
NO20084826L (no) Ny administrasjonsform av racecadotril
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006044449A3 (en) Cgrp receptor antagonists
DK2018169T3 (da) Anvendelse af 4,17-beta-dihydroxyandrost-4-en-3-on til behandling af cancer
WO2007146349A3 (en) Cgrp receptor antagonists
WO2006078554A3 (en) Cgrp receptor antagonists